MetaADEDB 2.0 @ LMMD
Daunorubicin
(GUGHGUXZJWAIAS-QQYBVWGSSA-N)
Structure
SMILES
COc1cccc2c1C(=O)c1c(C2=O)c(O)c2c(c1O)[C@@H](O[C@H]1C[C@H](N)[C@@H]([C@@H](O1)C)O)C[C@](C2)(O)C(=O)C.Cl
Molecular Formula:
C27H30ClNO10
Molecular Weight:
563.981
Log P:
2.5312
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
6
TPSA:
185.84
CAS Number(s):
23541-50-6
Synonym(s)
1.
Daunorubicin
2.
Daunomycin
3.
Rubidomycin
4.
Rubomycin
5.
Cerubidine
6.
Dauno-Rubidomycine
7.
Daunoblastin
8.
Daunoblastine
9.
Daunorubicin Hydrochloride
10.
NSC-82151
11.
Dauno Rubidomycine
12.
Hydrochloride, Daunorubicin
13.
NSC 82151
14.
NSC82151
External Link(s)
MeSHD003630
PubChem Compound657197
11342025
62770
ChEBI31456
CHEMBLCHEMBL1563
KEGGdr:D01264
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Febrile NeutropeniaFAERS: 29US FAERS
2HypotensionFAERS: 19US FAERS
3InfectionFAERS: 17US FAERS
4DehydrationFAERS: 9US FAERS
5SepsisFAERS: 9US FAERS
6StomatitisFAERS: 9US FAERS
7NeutropeniaFAERS: 8US FAERS
8Abdominal PainFAERS: 7US FAERS
9Catheter related infectionFAERS: 7US FAERS
10FatigueFAERS: 7US FAERS
11HypoxiaFAERS: 7US FAERS
12NauseaFAERS: 7US FAERS
13PneumonitisFAERS: 7US FAERS
14Weight decreasedFAERS: 7US FAERS
15AnorexiaFAERS: 6US FAERS
16ThrombocytopeniaFAERS: 6US FAERS
17White blood cell count decreasedFAERS: 6US FAERS
18ColitisFAERS: 5US FAERS
19DeliriumFAERS: 5US FAERS
20Ejection Fraction DecreasedFAERS: 5US FAERS
21Atrial FibrillationFAERS: 4US FAERS
22Respiratory FailureFAERS: 4US FAERS
23Respiratory distressFAERS: 4US FAERS
24Septic ShockFAERS: 4US FAERS
25AstheniaFAERS: 3US FAERS
26AtaxiaFAERS: 3US FAERS
27Cardiac ArrestFAERS: 3US FAERS
28ChillsFAERS: 3US FAERS
29Enterococcal infectionFAERS: 3US FAERS
30HeadacheFAERS: 3US FAERS
31HypophagiaFAERS: 3US FAERS
32Medication ErrorFAERS: 3US FAERS
33Neutropenic sepsisFAERS: 3US FAERS
34Neutrophil count decreasedFAERS: 3US FAERS
35PancytopeniaFAERS: 3US FAERS
36PneumoniaFAERS: 3US FAERS
37Sinus bradycardiaFAERS: 3US FAERS
38VomitingFAERS: 3US FAERS
39ArthralgiaFAERS: 2US FAERS
40Back PainFAERS: 2US FAERS
41Catheter site phlebitisFAERS: 2US FAERS
42Central nervous system lesionFAERS: 2US FAERS
43Clostridium colitisFAERS: 2US FAERS
44Depressed Level of ConsciousnessFAERS: 2US FAERS
45Disease ProgressionFAERS: 2US FAERS
46DizzinessFAERS: 2US FAERS
47DysuriaFAERS: 2US FAERS
48EpistaxisFAERS: 2US FAERS
49Expired drug administeredFAERS: 2US FAERS
50InfarctionFAERS: 2US FAERS
51Leukaemic infiltration brainFAERS: 2US FAERS
52Mental disorder due to a general medical conditionFAERS: 2US FAERS
53Mental status changesFAERS: 2US FAERS
54Myocardial InfarctionFAERS: 2US FAERS
55PainFAERS: 2US FAERS
56PetechiaeFAERS: 2US FAERS
57PruritusFAERS: 2US FAERS
58Pulmonary EmbolismFAERS: 2US FAERS
59Staphylococcus test positiveFAERS: 2US FAERS
60Troponin increasedFAERS: 2US FAERS
61Urinary IncontinenceFAERS: 2US FAERS
62AcidosisFAERS: 1US FAERS
63Acute myocardial infarctionFAERS: 1US FAERS
64Alanine Aminotransferase IncreasedFAERS: 1US FAERS
65AlkalosisFAERS: 1US FAERS
66Anaphylactoid ReactionFAERS: 1US FAERS
67AnxietyFAERS: 1US FAERS
68AppendicitisFAERS: 1US FAERS
69Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
70AspergillosisFAERS: 1US FAERS
71BlindnessFAERS: 1US FAERS
72Blood albumin decreasedFAERS: 1US FAERS
73Blood glucose increasedFAERS: 1US FAERS
74Blood potassium increasedFAERS: 1US FAERS
75CardiomegalyFAERS: 1US FAERS
76Cardiovascular insufficiencyFAERS: 1US FAERS
77CellulitisFAERS: 1US FAERS
78Chest discomfortFAERS: 1US FAERS
79Chest wall painFAERS: 1US FAERS
80CholecystitisFAERS: 1US FAERS
81Coma scale abnormalFAERS: 1US FAERS
82Complications of transplant surgeryFAERS: 1US FAERS
83Cytolytic hepatitisFAERS: 1US FAERS
84Deep Vein ThrombosisFAERS: 1US FAERS
85Duodenal ulcer perforationFAERS: 1US FAERS
86DysphasiaFAERS: 1US FAERS
87EnterocolitisFAERS: 1US FAERS
88Epstein-Barr virus associated lymphoproliferative disorderFAERS: 1US FAERS
89ExtravasationFAERS: 1US FAERS
90Facial ParesisFAERS: 1US FAERS
91Feeling jitteryFAERS: 1US FAERS
92Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
93General physical health deteriorationFAERS: 1US FAERS
94IleusFAERS: 1US FAERS
95ImmunosuppressionFAERS: 1US FAERS
96Inappropriate schedule of drug administrationFAERS: 1US FAERS
97Intervertebral disc disorderFAERS: 1US FAERS
98Klebsiella test positiveFAERS: 1US FAERS
99LethargyFAERS: 1US FAERS
100LeukoencephalopathyFAERS: 1US FAERS
101Malignant melanoma in situFAERS: 1US FAERS
102Meningeal disorderFAERS: 1US FAERS
103MeningismFAERS: 1US FAERS
104Metabolic acidosisFAERS: 1US FAERS
105MoaningFAERS: 1US FAERS
106Mucosal InfectionFAERS: 1US FAERS
107MutismFAERS: 1US FAERS
108MyalgiaFAERS: 1US FAERS
109NeuropathyFAERS: 1US FAERS
110Neutropenic colitisFAERS: 1US FAERS
111PalpitationsFAERS: 1US FAERS
112PancreatitisFAERS: 1US FAERS
113PeritonitisFAERS: 1US FAERS
114PhlebitisFAERS: 1US FAERS
115PresyncopeFAERS: 1US FAERS
116Renal tubular necrosisFAERS: 1US FAERS
117Respiratory arrestFAERS: 1US FAERS
118Ruptured cerebral aneurysmFAERS: 1US FAERS
119SinusitisFAERS: 1US FAERS
120Tardive DyskinesiaFAERS: 1US FAERS
121TremorFAERS: 1US FAERS
122Unresponsive to stimuliFAERS: 1US FAERS
123VIIth nerve paralysisFAERS: 1US FAERS
124VasculitisFAERS: 1US FAERS
125Ventricular DysfunctionFAERS: 1US FAERS
126Ventricular failureFAERS: 1US FAERS
127Visual ImpairmentFAERS: 1US FAERS
128Wound InfectionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.